1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REPLIGEN CORP.
103.38 -3.65 (-3.41%)
2.0M
XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The board meeting for Repligen Corp is scheduled for today, for the purpose of Repligen Corp Annual General Meeting for 2026 See details

Repligen Corp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents